LL-37 Kit

What Is LL-37 Peptide?

LL-37 is the principal human cathelicidin antimicrobial peptide. It is generated through proteolytic processing of the human cathelicidin precursor protein hCAP18, which is encoded by the CAMP gene.

The name LL-37 refers to two defining structural characteristics: the mature peptide begins with two leucine residues (LL) and consists of 37 amino-acid residues.

LL-37 has attracted substantial research interest because its biological activity extends beyond direct interactions with microorganisms. Experimental studies have examined its involvement in innate immune signaling, inflammatory responses, chemotaxis, membrane biology and tissue-response pathways.

LL-37 Amino-Acid Sequence and Structure

LL-37 is a cationic peptide containing 37 amino-acid residues. Its positive charge and amphipathic characteristics are important areas of research because they influence interactions between the peptide and biological membranes.

In membrane-associated environments, LL-37 can adopt an alpha-helical conformation. Researchers have investigated how this structural behavior contributes to peptide-membrane interactions and other biological functions.

LL-37, hCAP18 and the CAMP Gene

LL-37 does not initially exist as an isolated 37-residue peptide inside human cells. It originates from the larger precursor protein human cationic antimicrobial protein 18 (hCAP18).

hCAP18 is encoded by the CAMP gene. Enzymatic processing releases the C-terminal LL-37 sequence from the precursor, producing the mature peptide studied extensively in innate-immunity research.

LL-37 Antimicrobial Peptide Research

LL-37 is widely classified as an antimicrobial peptide (AMP). A major area of laboratory research involves its interaction with microbial membranes.

Because LL-37 is both cationic and amphipathic, investigators have examined how electrostatic and hydrophobic interactions influence its association with lipid membranes.

Experimental studies have evaluated LL-37 against numerous microorganisms under controlled laboratory conditions, including models involving Gram-positive bacteria, Gram-negative bacteria and fungal organisms.

LL-37 and Biofilm Research

LL-37 biofilm research is another important area of antimicrobial-peptide investigation.

Biofilms are structured microbial communities in which cells exist within a self-produced extracellular matrix. Their biology differs considerably from freely suspended microbial cells, making biofilms an important model for studying microbial organization, signaling and environmental persistence.

Researchers have examined LL-37 in experimental biofilm systems to investigate effects on processes such as surface attachment, microbial communication, biofilm development and membrane-associated activity.

These studies help researchers better understand the broader role antimicrobial peptides may play in host-microbe interactions.

LL-37 and Innate Immunity Research

LL-37 is an important research target in innate immunity, the collection of rapid biological defense mechanisms that respond to environmental and microbial signals.

Human cells associated with barrier tissues and immune responses can express cathelicidin-related molecules. This has led researchers to investigate LL-37 not simply as an antimicrobial peptide, but as a signaling molecule operating at the intersection of host defense, inflammation and cellular communication.

LL-37 and Immunomodulatory Signaling

One reason LL-37 remains an active research subject is that its biological behavior appears more complex than simple direct antimicrobial activity.

Experimental research has examined interactions involving chemotactic signaling, cytokine-associated pathways, immune-cell recruitment and receptor-mediated cellular communication.

These observations have contributed to LL-37 being studied as an immunomodulatory peptide as well as an antimicrobial peptide.

LL-37 and Inflammation Research

The relationship between LL-37 and inflammatory signaling is complex and context dependent.

Researchers have investigated LL-37 in models examining inflammatory mediators, immune-cell behavior, cellular stress and interactions between innate immune signaling pathways.

Depending on the experimental system, concentration, cellular environment and other variables, LL-37-associated responses may differ substantially. This makes the peptide particularly useful for mechanistic research into the regulation of inflammatory biology.

LL-37 and Tissue-Response Research

LL-37 has also been investigated in experimental models involving epithelial biology, keratinocytes, fibroblasts, endothelial cells and tissue-response signaling.

Laboratory studies have examined processes associated with cellular migration, barrier biology, angiogenic signaling and communication between immune and structural cells.

This area of research is often discussed in relation to wound-response biology. Such research describes experimental mechanisms and should not be interpreted as evidence that an LL-37 research product heals wounds or treats tissue injuries.

LL-37 Research Areas

LL-37 5mg Research Specifications

Why Is LL-37 Studied?

LL-37 is scientifically interesting because a single endogenous peptide participates in several interconnected areas of biological research.

Its cationic amphipathic structure makes it valuable for membrane and antimicrobial peptide research, while its endogenous role as a human cathelicidin makes it relevant to innate immune and host-defense biology.

At the same time, research involving inflammatory signaling, chemotaxis, cellular migration and tissue responses demonstrates why LL-37 is often studied as a multifunctional signaling peptide rather than exclusively as an antimicrobial molecule.

LL-37 Peptide FAQ